Cargando…
Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report
Rivaroxaban is one of the new anti-coagulants that inhibit Factor Xa and rarely cause rectus sheath hematoma and retroperitoneal haemorrhage which are uncommon, life-threatening complications. Here is a case of an elderly patient on rivaroxaban therapy for the stroke prevention in non-valvular atria...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Makerere Medical School
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794513/ https://www.ncbi.nlm.nih.gov/pubmed/31656515 http://dx.doi.org/10.4314/ahs.v19i2.55 |
| _version_ | 1783459312277913600 |
|---|---|
| author | Börekci, Elif |
| author_facet | Börekci, Elif |
| author_sort | Börekci, Elif |
| collection | PubMed |
| description | Rivaroxaban is one of the new anti-coagulants that inhibit Factor Xa and rarely cause rectus sheath hematoma and retroperitoneal haemorrhage which are uncommon, life-threatening complications. Here is a case of an elderly patient on rivaroxaban therapy for the stroke prevention in non-valvular atrial fibrillation who developed rectus sheath hematoma and retroperitoneal bleeding. |
| format | Online Article Text |
| id | pubmed-6794513 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Makerere Medical School |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67945132019-10-25 Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report Börekci, Elif Afr Health Sci Articles Rivaroxaban is one of the new anti-coagulants that inhibit Factor Xa and rarely cause rectus sheath hematoma and retroperitoneal haemorrhage which are uncommon, life-threatening complications. Here is a case of an elderly patient on rivaroxaban therapy for the stroke prevention in non-valvular atrial fibrillation who developed rectus sheath hematoma and retroperitoneal bleeding. Makerere Medical School 2019-06 /pmc/articles/PMC6794513/ /pubmed/31656515 http://dx.doi.org/10.4314/ahs.v19i2.55 Text en © 2019 Börekci E. Licensee African Health Sciences. This is an Open Access article distributed under the terms of the Creative commons Attribution License (https://creativecommons.org/licenses/BY/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Articles Börekci, Elif Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report |
| title | Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report |
| title_full | Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report |
| title_fullStr | Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report |
| title_full_unstemmed | Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report |
| title_short | Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report |
| title_sort | rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report |
| topic | Articles |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794513/ https://www.ncbi.nlm.nih.gov/pubmed/31656515 http://dx.doi.org/10.4314/ahs.v19i2.55 |
| work_keys_str_mv | AT borekcielif rectussheathhematomaandretroperitonealbleedingduetorivaroxabanacasereport |